Variation in a range of mTOR-related genes associates with intracranial volume and intellectual disability

[1]  Benjamin W Roberts.  Neuronal Migration Disorders. , 2019, Radiologic technology.

[2]  A. Takahashi,et al.  Pathologic Active mTOR Mutation in Brain Malformation with Intractable Epilepsy Leads to Cell-Autonomous Migration Delay. , 2017, The American journal of pathology.

[3]  D. Sabatini,et al.  mTOR Signaling in Growth, Metabolism, and Disease , 2017, Cell.

[4]  Raphael A. Bernier,et al.  denovo-db: a compendium of human de novo variants , 2016, Nucleic Acids Res..

[5]  Benjamin S Aribisala,et al.  Novel genetic loci underlying human intracranial volume identified through genome-wide association , 2016, Nature Neuroscience.

[6]  D. Page,et al.  Hyperconnectivity of prefrontal cortex to amygdala projections in a mouse model of macrocephaly/autism syndrome , 2016, Nature Communications.

[7]  J. French,et al.  Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study , 2016, The Lancet.

[8]  Tune H Pers,et al.  Gene set analysis for interpreting genetic studies. , 2016, Human molecular genetics.

[9]  Taylor J. Malone,et al.  Normalizing translation through 4E-BP prevents mTOR-driven cortical mislamination and ameliorates aberrant neuron integration , 2016, Proceedings of the National Academy of Sciences.

[10]  D. Rizopoulos,et al.  Sirolimus for epilepsy in children with tuberous sclerosis complex , 2016, Neurology.

[11]  L. Vissers,et al.  Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability , 2016, Nature Neuroscience.

[12]  Beth K. Martin,et al.  Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism. , 2016, JAMA neurology.

[13]  F. Hyder,et al.  Convulsive seizures from experimental focal cortical dysplasia occur independently of cell misplacement , 2016, Nature Communications.

[14]  T. Heskes,et al.  The statistical properties of gene-set analysis , 2016, Nature Reviews Genetics.

[15]  Juliane Freud,et al.  Culturing Nerve Cells , 2016 .

[16]  G. Mathern,et al.  An AKT3-FOXG1-Reelin Network Underlies Defective Migration in Human Focal Malformations of Cortical Development , 2015, Nature Medicine.

[17]  N. Katsanis,et al.  A human laterality disorder caused by a homozygous deleterious mutation in MMP21 , 2015, Journal of Medical Genetics.

[18]  J. Wheless.  Use of the mTOR inhibitor everolimus in a patient with multiple manifestations of tuberous sclerosis complex including epilepsy , 2015, Epilepsy & Behavior Case Reports.

[19]  Seonhee Kim,et al.  Impaired Reelin-Dab1 Signaling Contributes to Neuronal Migration Deficits of Tuberous Sclerosis Complex. , 2015, Cell reports.

[20]  M. Hurles,et al.  B56δ-related protein phosphatase 2A dysfunction identified in patients with intellectual disability. , 2015, The Journal of clinical investigation.

[21]  M. Cutrone,et al.  Molecular and Functional Characterization of Three Different Postzygotic Mutations in PIK3CA-Related Overgrowth Spectrum (PROS) Patients: Effects on PI3K/AKT/mTOR Signaling and Sensitivity to PIK3 Inhibitors , 2015, PloS one.

[22]  M. Ichikawa,et al.  Rheb activation disrupts spine synapse formation through accumulation of syntenin in tuberous sclerosis complex , 2015, Nature Communications.

[23]  Joris M. Mooij,et al.  MAGMA: Generalized Gene-Set Analysis of GWAS Data , 2015, PLoS Comput. Biol..

[24]  Seok-Gu Kang,et al.  Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy , 2015, Nature Medicine.

[25]  Y. Elgersma,et al.  Intact neuronal function in Rheb1 mutant mice: implications for TORC1-based treatments. , 2015, Human molecular genetics.

[26]  Thomas E. Nichols,et al.  Common genetic variants influence human subcortical brain structures , 2015, Nature.

[27]  Bradley S. Peterson,et al.  Loss of mTOR-Dependent Macroautophagy Causes Autistic-like Synaptic Pruning Deficits , 2014, Neuron.

[28]  Y. Ben-Ari,et al.  Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model , 2014, Nature Communications.

[29]  M. Kano,et al.  Selective activation of mTORC1 signaling recapitulates microcephaly, tuberous sclerosis, and neurodegenerative diseases. , 2014, Cell reports.

[30]  H. Nawa,et al.  mTOR signaling and its roles in normal and abnormal brain development , 2014, Front. Mol. Neurosci..

[31]  R. Hevner,et al.  Growth and folding of the mammalian cerebral cortex: from molecules to malformations , 2014, Nature Reviews Neuroscience.

[32]  Michael N. Hall,et al.  Making new contacts: the mTOR network in metabolism and signalling crosstalk , 2014, Nature Reviews Molecular Cell Biology.

[33]  Thomas E. Nichols,et al.  The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data , 2014, Brain Imaging and Behavior.

[34]  A. Bordey,et al.  mTORC1 targets the translational repressor 4E-BP2, but not S6 kinase 1/2, to regulate neural stem cell self-renewal in vivo. , 2013, Cell reports.

[35]  Nils Z. Borgesius,et al.  TORC1‐dependent epilepsy caused by acute biallelic Tsc1 deletion in adult mice , 2013, Annals of neurology.

[36]  Jie Chen,et al.  Duration of rapamycin treatment has differential effects on metabolism in mice. , 2013, Cell metabolism.

[37]  A. Bordey,et al.  Rheb Activation in Subventricular Zone Progenitors Leads to Heterotopia, Ectopic Neuronal Differentiation, and Rapamycin-Sensitive Olfactory Micronodules and Dendrite Hypertrophy of Newborn Neurons , 2013, The Journal of Neuroscience.

[38]  E. Thiele,et al.  Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial , 2013, The Lancet.

[39]  E. Klann,et al.  Exaggerated Translation Causes Synaptic and Behavioral Aberrations Associated with Autism , 2012, Nature.

[40]  E. Klann,et al.  Multiple components of eIF4F are required for protein synthesis-dependent hippocampal long-term potentiation. , 2013, Journal of neurophysiology.

[41]  B. V. van Bon,et al.  Diagnostic exome sequencing in persons with severe intellectual disability. , 2012, The New England journal of medicine.

[42]  B. Murphy,et al.  Excessive Activation of mTOR in Postnatally Generated Granule Cells Is Sufficient to Cause Epilepsy , 2012, Neuron.

[43]  L. Swiech,et al.  Mammalian Target of Rapamycin Complex 1 (mTORC1) and 2 (mTORC2) Control the Dendritic Arbor Morphology of Hippocampal Neurons* , 2012, The Journal of Biological Chemistry.

[44]  S. Gabriel,et al.  De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly , 2012, Nature Genetics.

[45]  J. Shendure,et al.  De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes , 2012, Nature Genetics.

[46]  Peter M. Klein,et al.  The Interaction between Early Life Epilepsy and Autistic-Like Behavioral Consequences: A Role for the Mammalian Target of Rapamycin (mTOR) Pathway , 2012, PloS one.

[47]  D. Sabatini,et al.  A unifying model for mTORC1-mediated regulation of mRNA translation , 2012, Nature.

[48]  Akira Sawa,et al.  In Utero Electroporation as a Tool For Genetic Manipulation In Vivo to Study Psychiatric Disorders , 2012, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[49]  D. Sabatini,et al.  mTOR Signaling in Growth Control and Disease , 2012, Cell.

[50]  J. Xu,et al.  Tsc1 mutant neural stem/progenitor cells exhibit migration deficits and give rise to subependymal lesions in the lateral ventricle. , 2011, Genes & development.

[51]  B. Sabatini,et al.  Loss of Tsc1 In Vivo Impairs Hippocampal mGluR-LTD and Increases Excitatory Synaptic Function , 2011, The Journal of Neuroscience.

[52]  C. Cho.  Frontier of Epilepsy Research - mTOR signaling pathway , 2011, Experimental & Molecular Medicine.

[53]  J. Platel,et al.  Single-cell Tsc1 knockout during corticogenesis generates tuber-like lesions and reduces seizure threshold in mice. , 2011, The Journal of clinical investigation.

[54]  D. Gutmann,et al.  Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex. , 2011, Human molecular genetics.

[55]  Emmanouil Collab.  A map of human genome variation from population-scale sequencing , 2011, Nature.

[56]  D. Gutmann,et al.  Tsc 2 gene inactivation causes a more severe epilepsy phenotype than Tsc 1 inactivation in a mouse model of Tuberous Sclerosis Complex , 2011 .

[57]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[58]  Mustafa Sahin,et al.  Tsc2-Rheb Signaling Regulates EphA-Mediated Axon Guidance , 2009, Nature Neuroscience.

[59]  K. Lunetta,et al.  Methods in Genetics and Clinical Interpretation Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Design of Prospective Meta-Analyses of Genome-Wide Association Studies From 5 Cohorts , 2010 .

[60]  Ying-Hua Li,et al.  Rheb and mTOR Regulate Neuronal Polarity through Rap1B* , 2008, Journal of Biological Chemistry.

[61]  Mustafa Sahin,et al.  Response of a Neuronal Model of Tuberous Sclerosis to Mammalian Target of Rapamycin (mTOR) Inhibitors: Effects on mTORC1 and Akt Signaling Lead to Improved Survival and Function , 2008, The Journal of Neuroscience.

[62]  J. Cheadle,et al.  Cognitive deficits in Tsc1+/−mice in the absence of cerebral lesions and seizures , 2007, Annals of neurology.

[63]  R. Kahn,et al.  Genetic influences on human brain structure: A review of brain imaging studies in twins , 2007, Human brain mapping.

[64]  Henry Kennedy,et al.  Cell-cycle control and cortical development , 2007, Nature Reviews Neuroscience.

[65]  P. Arlotta,et al.  Neuronal subtype specification in the cerebral cortex , 2007, Nature Reviews Neuroscience.

[66]  Y. Jan,et al.  Activity- and mTOR-Dependent Suppression of Kv1.1 Channel mRNA Translation in Dendrites , 2006, Science.

[67]  Wei Zhang,et al.  Pten Regulates Neuronal Arborization and Social Interaction in Mice , 2006, Neuron.

[68]  Bernardo L Sabatini,et al.  Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2 , 2005, Nature Neuroscience.

[69]  W. Kolch.  Coordinating ERK/MAPK signalling through scaffolds and inhibitors , 2005, Nature Reviews Molecular Cell Biology.

[70]  J. Blenis,et al.  Tuberous Sclerosis Complex Gene Products, Tuberin and Hamartin, Control mTOR Signaling by Acting as a GTPase-Activating Protein Complex toward Rheb , 2003, Current Biology.

[71]  N. Nakatsuji,et al.  Efficient gene transfer into the embryonic mouse brain using in vivo electroporation. , 2001, Developmental biology.

[72]  G. Banker,et al.  Culturing nerve cells , 1998 .

[73]  P. O'Connell,et al.  Identification and characterization of transcripts from the neurofibromatosis 1 region: the sequence and genomic structure of EVI2 and mapping of other transcripts. , 1990, Genomics.